PRP, Exosomes, and Adjunct Therapy Glossary

One arrives at the PRP and exosome conversation expecting a clean vocabulary, and the Korean corridor — and this matters — does not offer one. The terminology sits across at least three registers: the haematology-derived PRP and PRF lexicon, the cellular-biology vesicle taxonomy, and the aesthetic-medicine adjunct register that pairs these preparations with microneedling, with radiofrequency, with the cellular protocols themselves. What follows is a categorical glossary of fifty terms a careful patient is likely to encounter in a Cheongdam or Apgujeong consult on PRP, exosomes, and the wider adjunct register — the definitions calibrated, the cross-references drawn, the regulatory standing articulated where it matters. 睇清楚個語言先講療程 — read the vocabulary cleanly first, the protocol after, as the corridor's older phrasing has it.

A-Z index

The fifty terms are grouped alphabetically below; the index lets a reader jump to the relevant register. Activator · Adjunct therapy · Anucleate vesicle · Autologous conditioned plasma · Buffy coat · Centrifugation · Citrate anticoagulant · Concentration factor · CD9 / CD63 / CD81 · Double-spin protocol · Erythrocyte · Exosome · Extracellular vesicle · Fibrin matrix · Growth factor cocktail · Hyaluronic acid pairing · Injection depth · Kit-based system · Leukocyte-poor PRP · Leukocyte-rich PRP · Lyophilised exosome · Mesotherapy · Microneedling · Microvesicle · Multivesicular body · Nanoparticle tracking analysis · Open system · Particle count · PDRN · Platelet · Platelet-poor plasma · Platelet-rich fibrin · Platelet-rich plasma · Polynucleotide · Pulse fluence · Radiofrequency adjunct · Red blood cell layer · RF microneedling · Salmon DNA filler · Single-spin protocol · Skin booster · Stamp microneedling · Subcision · Topical exosome · Tranexamic acid · Tumescent anaesthesia · Ultrasound adjunct · Vesicle isolation · Volumiser pairing · White blood cell concentration.

A

The A-terms cover the activation step, the adjunct framing, and the vesicle taxonomy a patient encounters at the start of the PRP and exosome consult.

Activator

The reagent — most commonly calcium chloride, calcium gluconate, or autologous thrombin — added to a platelet-rich-plasma preparation to initiate the platelet-degranulation cascade and the fibrin-polymerisation arc. The activator step is optional in the wider PRP register; some protocols inject the platelet concentrate unactivated and rely on in-situ activation at the injection site, while others activate ex vivo before administration. The conservative Gangnam corridor articulates the activator decision as part of the protocol's clinical reasoning rather than as a marketing distinction. See also: fibrin matrix, platelet-rich fibrin, platelet.

Adjunct therapy

A treatment paired with a primary cellular or aesthetic protocol — most commonly PRP paired with microneedling, exosome topical paired with radiofrequency microneedling, or polynucleotide paired with skin booster injection — to address a complementary indication or to extend the primary protocol's register. The adjunct framing is the conservative reading of much of the PRP and exosome category; the careful Cheongdam consult is likelier to articulate exosomes and PRP as adjuncts to a wider regimen than as standalone protocols. The adjunct register sits where the published evidence is meaningfully thinner than the marketing copy may suggest. See also: microneedling, RF microneedling, skin booster.

Anucleate vesicle

A cell-derived vesicle that lacks a nucleus — the structural feature that distinguishes the exosome and microvesicle population from intact cells under the regulatory and biological reading. The anucleate framing is part of why the exosome and extracellular-vesicle category sits on a different regulatory shelf than the cultured-cellular-product category in most jurisdictions; the absence of replicating cellular material changes the classification arc. A patient at consult should expect the anucleate framing to be discussed where the practice offers exosome protocols rather than collapsed into a marketing claim. See also: exosome, extracellular vesicle, microvesicle.

Autologous conditioned plasma (ACP)

A specific platelet-concentrate register — single-spin, leukocyte-poor, and typically delivered through a closed double-syringe system — calibrated for orthopaedic and aesthetic-medicine applications. The ACP framing is the trade-name register of one of the longstanding kit-based systems; a patient encountering ACP at consult should expect the protocol to be discussed under the leukocyte-poor PRP register rather than as a categorically distinct preparation. The kit-based register makes the protocol reproducible across the consult-room arc. See also: kit-based system, leukocyte-poor PRP, single-spin protocol.

B

The B-terms address the buffy-coat layer — the cellular interface that sits at the centre of the PRP preparation's taxonomy.

Buffy coat

The thin cellular layer that forms between the plasma supernatant and the erythrocyte sediment in a centrifuged whole-blood sample — containing the platelet population, the leukocyte population, and a small erythrocyte fraction at the interface. The buffy-coat layer is the structural feature that distinguishes leukocyte-rich PRP — drawn through the buffy coat — from leukocyte-poor PRP, which is drawn above the buffy coat. The careful regenerative-medicine consult articulates the buffy-coat decision as part of the protocol's clinical reasoning. See also: leukocyte-poor PRP, leukocyte-rich PRP, centrifugation, erythrocyte.

C

The C-terms sit at the centrifugation arc — the laboratory step that separates the platelet concentrate from the wider whole-blood sample — and at the surface-marker register that characterises the exosome population.

Centrifugation

The physical separation step under which a whole-blood sample is fractionated by density across a defined rotational protocol — speed expressed in g-force, duration expressed in minutes, and the resulting cellular layers articulated under a single-spin or double-spin register. The centrifugation arc sits at the centre of every PRP protocol; the practice's choice of g-force and duration calibrates the platelet concentration, the leukocyte fraction, and the erythrocyte carry-over. A patient at consult should expect the centrifugation framework to be referenced honestly rather than collapsed into the brand name of the kit. See also: double-spin protocol, single-spin protocol, buffy coat.

Citrate anticoagulant

The anticoagulant — most commonly sodium citrate or acid-citrate-dextrose — added to the whole-blood collection tube at draw to prevent the coagulation cascade from initiating before the centrifugation step. The citrate register is part of the kit-based system's reproducibility framework; the calibrated citrate-to-blood ratio underpins the platelet-concentrate's quality. A patient at consult is unlikely to encounter the citrate detail in marketing copy, but the careful practice references the kit's anticoagulant register where the protocol is discussed in depth. See also: kit-based system, platelet, centrifugation.

Concentration factor

The ratio of the platelet concentration in the prepared PRP to the platelet concentration in the patient's baseline whole blood — most commonly expressed as a multiple (a 3x, 5x, or 8x concentration factor, depending on the protocol's register). The concentration-factor reading is the cleanest single descriptor of where a PRP preparation sits in the wider taxonomy; the conservative aesthetic-medicine corridor tends to favour a 3x to 5x register, while the orthopaedic-medicine literature has explored higher concentration registers. See also: platelet, platelet-rich plasma, double-spin protocol.

CD9 / CD63 / CD81

The three tetraspanin surface markers most commonly used to characterise the exosome population in flow-cytometric and Western-blot assays — drawn from the wider extracellular-vesicle marker register and treated as the standard exosome-identification panel in much of the published literature. A practice that articulates the surface-marker characterisation framework cleanly at consult is, in the careful reading, working with a more disciplined exosome supply chain than a practice that does not. The marker register is part of the lot-release framework. See also: exosome, extracellular vesicle, vesicle isolation.

D

The D-terms cover the double-spin centrifugation register — the longer laboratory arc that produces the higher-concentration PRP preparations.

Double-spin protocol

A centrifugation arc that runs two sequential spins on the whole-blood sample — the first separating the cellular fractions broadly, the second concentrating the platelet population from the plasma supernatant — to produce a higher concentration-factor PRP preparation than the single-spin register can deliver. The double-spin protocol sits at the centre of the higher-concentration aesthetic and orthopaedic registers; the longer laboratory arc is balanced against the procedural complexity and the open-system risk where the protocol is run outside a closed kit. See also: single-spin protocol, concentration factor, open system.

E

The E-terms cover the erythrocyte fraction, the exosome category, and the wider extracellular-vesicle taxonomy a patient encounters across the PRP and vesicle-therapy registers.

Erythrocyte

The red blood cell — the most numerous cellular fraction in whole blood and the layer that sediments at the bottom of the centrifuged sample under the standard PRP protocol. The erythrocyte carry-over into a PRP preparation is one of the markers a careful practice tracks; high erythrocyte contamination correlates, in some published registers, with a more inflammatory injection-site response. The careful aesthetic-medicine consult treats erythrocyte minimisation as part of the protocol's quality framework. See also: red blood cell layer, buffy coat, leukocyte-poor PRP.

Exosome

A small extracellular vesicle — typically 30 to 150 nanometres in diameter, anucleate, and bound by a lipid-bilayer membrane — released from the multivesicular body of a parent cell and carrying a cargo of proteins, lipids, and nucleic acids that may participate in paracrine cell-to-cell signalling. The exosome category sits at the centre of much of the recent regenerative-medicine marketing register; the conservative reading is the adjunct framing — paired with microneedling, with radiofrequency, with cellular protocols — rather than the standalone-therapy framing some practices articulate. The regulatory standing varies meaningfully across jurisdictions. See also: anucleate vesicle, extracellular vesicle, multivesicular body, microvesicle.

Extracellular vesicle

The wider taxonomic category that contains exosomes, microvesicles, and apoptotic bodies — defined by the lipid-bilayer-bound, cell-derived, anucleate framing the cellular-biology literature articulates. The extracellular-vesicle framing is the more disciplined register; the broader category is what the published literature increasingly references where the older marketing copy says exosome. A practice that uses the extracellular-vesicle framing at consult is, in the careful reading, articulating a cleaner relationship to the published evidence than one that uses exosome as a catch-all. See also: exosome, microvesicle, anucleate vesicle.

F

The F-term covers the fibrin matrix that emerges from platelet activation and underpins the platelet-rich-fibrin register.

Fibrin matrix

The three-dimensional protein network that polymerises from fibrinogen under the activation cascade — initiated by calcium, by thrombin, or by in-situ activation at the injection site — and provides a scaffold within which the platelet-derived growth factors are released across a sustained timeline. The fibrin-matrix register sits at the centre of the platelet-rich-fibrin category; the slower release kinetics distinguish PRF from the more immediate PRP register. The careful regenerative-medicine consult articulates the matrix decision as part of the protocol's clinical reasoning. See also: activator, platelet-rich fibrin, growth factor cocktail.

G

The G-term covers the growth-factor population — the bioactive cargo that underpins the PRP register's therapeutic framing.

Growth factor cocktail

The mixed population of bioactive proteins released from the platelet alpha-granules upon activation — including platelet-derived growth factor, transforming growth factor beta, vascular endothelial growth factor, epidermal growth factor, and the wider register the published literature articulates. The growth-factor cocktail is the pharmacological framing through which the PRP register reads its mechanism; the conservative consult articulates the cocktail honestly — a complex, variable mixture rather than a calibrated single agent — and the patient is treated to the hedged register the literature supports. See also: cytokine, platelet, platelet-rich plasma.

H

The H-term covers the hyaluronic-acid pairing — the most common adjunct framing for the PRP and exosome register in the Korean aesthetic-medicine corridor.

Hyaluronic acid pairing

The protocol register under which a PRP, polynucleotide, or exosome preparation is paired with a hyaluronic-acid skin booster or volumising filler — most commonly across a multi-session arc that distributes the injection events across a four-to-eight-week window. The HA-pairing framing is the conservative aesthetic-medicine corridor's most common adjunct register; the careful Cheongdam consult articulates the pairing as a clinical reasoning rather than a marketing bundle. See also: skin booster, volumiser pairing, mesotherapy.

I

The I-term covers the injection-depth register — a procedural detail the careful consult articulates as part of the protocol's clinical reasoning.

Injection depth

The anatomical layer at which the PRP, exosome, or polynucleotide preparation is delivered — most commonly the intradermal layer for skin-quality indications, the subdermal layer for volumising and structural indications, and the supraperiosteal layer for deeper structural support where the protocol's register supports it. The injection-depth decision is calibrated to the indication; the careful Gangnam consult articulates the depth framework cleanly rather than collapsing the question into a generic protocol description. See also: mesotherapy, microneedling, skin booster.

K

The K-term covers the kit-based system register — the closed-system framework that underpins much of the reproducible PRP corridor.

Kit-based system

A closed, single-use PRP-preparation system — most commonly comprising a pre-loaded anticoagulant collection tube, a calibrated centrifugation protocol, and a sterile transfer arc — that constrains the open-system contamination risk and standardises the concentration factor across the consult-room arc. The kit-based register is the cleaner regulatory framing; the open-system register depends meaningfully on the practice's laboratory discipline. The careful aesthetic-medicine corridor in Cheongdam tends to articulate the kit register at consult. See also: open system, single-spin protocol, autologous conditioned plasma.

L

The L-terms cover the leukocyte-poor and leukocyte-rich PRP registers, plus the lyophilised exosome category.

Leukocyte-poor PRP

A platelet-concentrate preparation drawn from above the buffy coat in the centrifuged sample — minimising the leukocyte fraction and producing a less inflammatory injection-site profile under most published registers. The leukocyte-poor framing is the conservative aesthetic-medicine corridor's preferred register; the lower inflammatory profile aligns with the dermal-quality and rejuvenation indications where the PRP protocol is most commonly applied in the Korean corridor. See also: buffy coat, leukocyte-rich PRP, platelet-rich plasma.

Leukocyte-rich PRP

A platelet-concentrate preparation drawn through the buffy coat — including the leukocyte fraction in the prepared sample, with the higher inflammatory mediator profile the white-cell population carries. The leukocyte-rich register is more commonly encountered in the orthopaedic and tendinopathy corridors than in the aesthetic-medicine register; the higher inflammatory profile is read in the orthopaedic literature as a feature rather than a limitation for select indications. The careful consult articulates the leukocyte decision as part of the protocol's reasoning. See also: buffy coat, leukocyte-poor PRP, white blood cell concentration.

Lyophilised exosome

An exosome preparation that has been freeze-dried under controlled lyophilisation conditions and stored as a stable powder — typically reconstituted with sterile diluent at the consult-room point of use. The lyophilised register is the format under which most of the commercially available exosome products in the Korean aesthetic-medicine corridor are supplied; the stability profile underpins the product's logistical register. A patient at consult should expect the supplier, the lot identification, and the regulatory standing of the exosome product to be articulated honestly. See also: exosome, vesicle isolation, topical exosome.

M

The M-terms cover the mesotherapy register, the microneedling category, and the wider vesicle taxonomy that sits behind the exosome-product framing.

Mesotherapy

The injection register under which a small-volume cocktail — most commonly hyaluronic acid, polynucleotide, vitamin or amino-acid adjuncts, and select cellular or vesicle preparations — is delivered across a multi-point intradermal grid. The mesotherapy framing is part of the conservative aesthetic-medicine corridor's vocabulary; the careful Cheongdam consult articulates the mesotherapy register cleanly rather than as a generic skin-booster claim. See also: skin booster, hyaluronic acid pairing, injection depth.

Microneedling

The procedural register under which a calibrated array of fine needles creates a controlled grid of micro-channels through the epidermis and into the upper dermis — under either a stamp or a roller framework — to support topical-product penetration and to initiate a localised wound-healing arc. The microneedling category is the most common adjunct framing for PRP and exosome topical applications; the conservative reading pairs the device-based microneedling arc with the topical or injectable preparation under a single consult-room session. See also: stamp microneedling, RF microneedling, topical exosome.

Microvesicle

An extracellular vesicle that buds directly from the parent cell's plasma membrane — typically 100 to 1000 nanometres in diameter, larger than the exosome population, and distinguished from exosomes by the biogenesis arc rather than by the lipid-bilayer framing. The microvesicle category sits beside the exosome category in the wider extracellular-vesicle taxonomy; much of the marketing copy that uses exosome as a catch-all is, more accurately, addressing the wider extracellular-vesicle population. See also: exosome, extracellular vesicle, multivesicular body.

Multivesicular body

The intracellular endosomal compartment that gives rise to the exosome population — through the inward-budding of the limiting membrane and the subsequent release of the internal vesicle population into the extracellular space upon fusion with the plasma membrane. The multivesicular-body framing is the cleaner cellular-biology reading of the exosome category; the careful exosome consult is likelier to articulate the biogenesis arc than the catch-all marketing register. See also: exosome, anucleate vesicle, extracellular vesicle.

N

The N-term covers the nanoparticle-tracking-analysis assay — the laboratory framework under which exosome preparations are characterised.

Nanoparticle tracking analysis (NTA)

A laboratory technique that tracks the Brownian motion of individual nanoparticles in a dilute suspension across a calibrated optical assay — calculating particle size distribution and concentration under the Stokes-Einstein framework. NTA sits at the centre of the exosome-characterisation register; particle size and particle count are the two cleanest descriptors of where an exosome preparation sits in the wider taxonomy. A practice that references NTA characterisation at consult is, in the careful reading, articulating a cleaner exosome supply chain than one that does not. See also: particle count, vesicle isolation, exosome.

O

The O-term covers the open-system PRP register — the laboratory framing that depends on the practice's discipline.

Open system

A PRP-preparation register under which the centrifuged sample is transferred between tubes through open pipetting steps rather than through a closed-syringe kit — relying on the practice's laboratory discipline to limit contamination across the preparation arc. The open-system framing supports a wider customisation register — variable concentration factors, variable leukocyte fractions, variable activator decisions — but the contamination-control burden sits with the practice. The conservative reading favours the kit-based register where the protocol's reproducibility matters. See also: kit-based system, double-spin protocol, centrifugation.

P

The P-terms cover the particle-count assay, the platelet population, and the wider platelet-rich-plasma and platelet-rich-fibrin registers — the densest cluster of vocabulary in the glossary.

Particle count

The number of nanoparticles per millilitre in a prepared exosome or extracellular-vesicle product — most commonly measured under nanoparticle tracking analysis and reported as part of the lot-release framework. Particle count is the cleanest single descriptor of an exosome preparation's potency register; the careful aesthetic-medicine consult articulates the particle-count framework rather than collapsing the question into a generic dose claim. See also: nanoparticle tracking analysis, exosome, vesicle isolation.

PDRN

Polydeoxyribonucleotide — a low-molecular-weight nucleic-acid preparation derived under most commercial registers from salmon or trout sperm DNA — used in the Korean aesthetic-medicine corridor as a skin-booster injectable and, under select indications, as a tissue-repair adjunct. The PDRN register sits beside the polynucleotide and salmon-DNA-filler framing; the products vary meaningfully across the brand register, and the careful consult articulates the brand and the dose framework cleanly. See also: polynucleotide, salmon DNA filler, skin booster.

Platelet

The small, anucleate cellular fragment derived from megakaryocyte cytoplasm — circulating in whole blood at a baseline concentration of approximately 150 to 400 thousand per microlitre — and serving as the source of the growth-factor cocktail the PRP register articulates. The platelet population sits at the centre of the PRP and PRF taxonomies; the careful regenerative-medicine consult articulates the platelet biology cleanly rather than as a generic descriptor. See also: growth factor cocktail, platelet-rich plasma, buffy coat.

Platelet-poor plasma (PPP)

The supernatant fraction drawn from above the platelet pellet in a centrifuged sample — containing the plasma proteins and a low platelet concentration relative to the prepared PRP. PPP is sometimes used as a co-adjunct in select aesthetic-medicine protocols and as a topical adjunct after microneedling under select registers; the conservative reading treats PPP as a niche category rather than a primary-protocol register. See also: platelet-rich plasma, centrifugation, plasma.

Platelet-rich fibrin (PRF)

A platelet-concentrate preparation produced under a centrifugation protocol that allows the fibrin matrix to polymerise within the prepared sample — typically without an exogenous anticoagulant and without an exogenous activator — producing a slower-release platelet-derived growth-factor profile than the standard PRP register. The PRF framing is most commonly encountered in the dental and the aesthetic-medicine corridors; the slower-release kinetics differentiate the protocol's clinical reasoning from the more immediate PRP register. See also: fibrin matrix, platelet-rich plasma, activator.

Platelet-rich plasma (PRP)

A platelet-concentrate preparation derived from the patient's own whole blood under a centrifugation protocol — characterised by a defined concentration factor relative to the baseline platelet count, by the leukocyte fraction the protocol carries, and by the activator decision the practice articulates. The PRP register sits at the centre of the autologous adjunct category; the careful aesthetic-medicine and orthopaedic-medicine consults articulate the protocol's parameters cleanly rather than under a generic brand framing. See also: concentration factor, leukocyte-poor PRP, leukocyte-rich PRP, growth factor cocktail.

Polynucleotide

A long-chain nucleic-acid preparation — most commonly derived under salmon or trout sperm-DNA registers, calibrated under a controlled molecular-weight framework, and supplied through select Korean and European brand-name lines — used in the aesthetic-medicine corridor as a skin-booster injectable. The polynucleotide register sits beside the PDRN framing; the careful consult articulates the brand and the molecular-weight framework rather than as a generic salmon-DNA claim. See also: PDRN, salmon DNA filler, skin booster.

Pulse fluence

The energy delivered per unit area in a single pulse of a device-based aesthetic protocol — most commonly expressed in joules per square centimetre — and a parameter the careful consult articulates where the PRP or exosome adjunct is paired with a laser, radiofrequency, or ultrasound device. The pulse-fluence framework is part of the device's protocol reasoning rather than the PRP and exosome category itself, but the parameter is encountered at consult where the adjunct framing is articulated. See also: radiofrequency adjunct, RF microneedling, ultrasound adjunct.

R

The R-terms cover the radiofrequency adjunct register, the red-blood-cell layer, and the RF-microneedling category.

Radiofrequency adjunct

The pairing under which a PRP, exosome, or polynucleotide preparation is delivered alongside a radiofrequency device-based protocol — most commonly under a single consult-room session that runs the device first and the topical or injectable second. The RF-adjunct register sits beside the laser and ultrasound adjunct framings; the careful Gangnam consult articulates the adjunct decision under the indication's clinical reasoning rather than as a generic combination. See also: RF microneedling, pulse fluence, ultrasound adjunct.

Red blood cell layer

The dense, sediment-zone layer that forms at the bottom of a centrifuged whole-blood sample — comprising the erythrocyte fraction and a small carry-over of leukocytes at the upper interface. The red-blood-cell layer is the structural reference under which the buffy-coat and plasma-supernatant layers are read; the careful PRP-preparation arc minimises the erythrocyte carry-over into the prepared concentrate. See also: erythrocyte, buffy coat, centrifugation.

RF microneedling

A device category that combines the microneedling array with a radiofrequency-energy delivery framework — depositing thermal energy at calibrated subdermal depths along the needle track. RF microneedling sits at the centre of much of the recent Korean aesthetic-medicine adjunct corridor; the device is most commonly paired with a topical exosome application after the procedural arc, under the conservative reading of the exosome category. See also: microneedling, topical exosome, radiofrequency adjunct.

S

The S-terms cluster the salmon-DNA-filler register, the single-spin protocol, the skin-booster category, the stamp-microneedling format, and the subcision adjunct.

Salmon DNA filler

The polynucleotide and PDRN injectable category — derived under controlled fish-DNA registers, supplied through select Korean and European brand lines, and used in the aesthetic-medicine corridor under skin-booster and tissue-repair indications. The salmon-DNA framing is the consumer-facing register; the more disciplined consult articulates the brand and the molecular-weight framework cleanly. See also: PDRN, polynucleotide, skin booster.

Single-spin protocol

A centrifugation arc that runs a single spin on the whole-blood sample — separating the cellular fractions broadly and drawing the platelet concentrate from above the buffy coat under a leukocyte-poor register, or through the buffy coat under a leukocyte-rich register. The single-spin framing is the most common kit-based PRP register; the protocol's reproducibility underpins the conservative consult-room arc. See also: double-spin protocol, kit-based system, leukocyte-poor PRP.

Skin booster

The aesthetic-medicine category under which a low-viscosity hyaluronic-acid, polynucleotide, or vesicle-derived preparation is delivered across a multi-point intradermal grid for skin-quality indications — typically across a multi-session arc that distributes the injection events across a four-to-eight-week window. The skin-booster register sits beside the volumising-filler category; the indications, the products, and the protocol arcs are meaningfully different across the two registers. See also: hyaluronic acid pairing, mesotherapy, polynucleotide.

Stamp microneedling

A microneedling format under which a flat-array device delivers a discrete needle stamp into the target tissue — distinct from the roller-microneedling format and from the device-driven oscillating microneedling category. The stamp register supports a precise injection-grid framework where the practice pairs the microneedling arc with a topical exosome or PRP application. See also: microneedling, RF microneedling, topical exosome.

Subcision

A procedural register under which a fine cannula or needle is passed beneath a depressed scar or fibrotic tissue band to release the subdermal tethering — most commonly paired in the Korean corridor with a PRP, exosome, or polynucleotide adjunct delivered into the released subdermal space. The subcision adjunct framing is one of the more disciplined registers in the wider category; the careful consult articulates the indication, the cannula size, and the adjunct decision cleanly. See also: adjunct therapy, injection depth, mesotherapy.

T

The T-terms cover the topical exosome register, the tranexamic-acid adjunct, and the tumescent-anaesthesia framework.

Topical exosome

An exosome preparation applied to the skin surface after a microneedling, RF-microneedling, or laser arc — relying on the device-created micro-channels and the disrupted barrier function to support penetration into the upper dermis. The topical-exosome register is the most common adjunct framing under which the exosome category is delivered in the Korean aesthetic-medicine corridor; the conservative reading favours the topical-after-device pairing over the standalone-injection framing where the regulatory standing of the exosome product is uncertain. See also: exosome, microneedling, RF microneedling.

Tranexamic acid

A small-molecule antifibrinolytic agent — used in the Korean aesthetic-medicine corridor under a mesotherapy injection register and an oral register for melasma and pigmentation indications, often paired with an exosome or polynucleotide adjunct under a wider regimen. The tranexamic-acid register sits beside the cellular and vesicle-derived categories rather than within them; the careful consult articulates the agent honestly under the pigmentation-indication framing. See also: mesotherapy, adjunct therapy, skin booster.

Tumescent anaesthesia

The local-anaesthesia framework under which a dilute lignocaine and adrenaline solution is infiltrated into the subcutaneous tissue ahead of a procedural arc — most commonly encountered in the Korean corridor in the lipoaspirate and subcision registers, and in the wider PRP-adjunct framing where the procedural depth supports it. The tumescent register is part of the procedural-safety architecture; the careful consult articulates the framework honestly rather than collapsing the question into a generic anaesthesia claim. See also: subcision, injection depth.

U

The U-term covers the ultrasound-adjunct register — one of the device-based pairings the conservative consult articulates.

Ultrasound adjunct

The pairing under which a PRP, exosome, or polynucleotide preparation is delivered alongside an ultrasound-based device protocol — most commonly a high-intensity-focused-ultrasound or microfocused-ultrasound arc — under a single consult-room session that runs the device first and the topical or injectable second. The ultrasound-adjunct register sits beside the radiofrequency and laser pairings; the careful Gangnam consult articulates the adjunct decision under the indication's clinical reasoning. See also: radiofrequency adjunct, RF microneedling, pulse fluence.

V

The V-terms cover the vesicle-isolation framework and the volumising-filler pairing.

Vesicle isolation

The laboratory framework under which an exosome or extracellular-vesicle preparation is purified from the cell-culture supernatant or biological-fluid source — most commonly under an ultracentrifugation protocol, a tangential-flow filtration arc, a size-exclusion chromatography framework, or a hybrid combination. The vesicle-isolation register is part of the lot-release framework the careful exosome supplier articulates; a practice that references the isolation method at consult is, in the conservative reading, articulating a cleaner supply chain than one that does not. See also: exosome, extracellular vesicle, nanoparticle tracking analysis.

Volumiser pairing

The protocol register under which a PRP, polynucleotide, or exosome preparation is paired with a higher-viscosity hyaluronic-acid filler — most commonly across a sequential session arc that delivers the structural volumising step first and the skin-quality adjunct in a subsequent session. The volumiser-pairing framing is part of the conservative aesthetic-medicine corridor's regimen vocabulary; the careful Cheongdam consult articulates the sequence cleanly rather than as a generic combination. See also: hyaluronic acid pairing, skin booster, mesotherapy.

W

The W-term covers the white-blood-cell concentration register — a parameter the careful consult articulates as part of the PRP protocol's clinical reasoning.

White blood cell concentration

The leukocyte concentration in a prepared PRP sample relative to the patient's baseline whole-blood leukocyte count — a parameter the careful consult articulates alongside the platelet concentration factor. The white-blood-cell concentration distinguishes leukocyte-rich PRP — drawn through the buffy coat — from leukocyte-poor PRP, which is drawn above the buffy coat. The careful aesthetic-medicine corridor in Cheongdam tends to favour the leukocyte-poor register for the skin-quality indications. See also: leukocyte-poor PRP, leukocyte-rich PRP, buffy coat, concentration factor.

Frequently asked questions

Are PRP and exosome protocols regulated under the same framework in Korea?

No — and this matters at consult. PRP, drawn from the patient's own whole blood and re-administered under a minimal-manipulation register, sits on a meaningfully lighter regulatory footing than the exosome category, which the Ministry of Food and Drug Safety reads under a tighter cellular-derivative framework. A patient should expect the practice to articulate the regulatory standing of the specific exosome product rather than collapse the question into a generic claim.

What does concentration factor mean in PRP, and why does it matter?

Concentration factor is the ratio of platelets in the prepared PRP to the patient's baseline platelet count — typically expressed as 3x, 5x, or 8x. The conservative aesthetic-medicine corridor tends to favour a 3x to 5x register; the orthopaedic literature has explored higher concentrations. The parameter is the cleanest single descriptor of where a PRP preparation sits in the wider taxonomy.

Are exosomes injected or applied topically in the Korean aesthetic-medicine corridor?

Most commonly applied topically after a microneedling, RF-microneedling, or laser arc — relying on the device-created micro-channels for penetration. The conservative reading favours the topical-after-device pairing over the standalone-injection framing where the regulatory standing of the exosome product is uncertain. The practice's articulation of the delivery framework is part of the careful consult.

What is the difference between leukocyte-poor and leukocyte-rich PRP?

Leukocyte-poor PRP is drawn from above the buffy coat and minimises the white-blood-cell fraction, producing a less inflammatory injection-site profile favoured by the aesthetic-medicine register. Leukocyte-rich PRP is drawn through the buffy coat and includes the leukocyte fraction, more commonly used in orthopaedic and tendinopathy corridors where the higher inflammatory profile is read as a feature.

What does NTA characterisation tell you about an exosome product?

Nanoparticle tracking analysis reports the particle size distribution and the particle count per millilitre — the two cleanest descriptors of where an exosome preparation sits in the taxonomy. A practice that references NTA characterisation at consult is, in the careful reading, articulating a cleaner supply chain than one that does not. The marker register is part of the lot-release framework.

Are PDRN and polynucleotide the same thing?

They sit beside each other in the wider salmon-DNA-derivative register but are not identical. PDRN is the lower-molecular-weight polydeoxyribonucleotide framing, while polynucleotide refers to the longer-chain register — both supplied through select Korean and European brand lines under controlled molecular-weight calibration. The careful consult articulates the brand and the molecular-weight framework rather than collapsing the question into a generic salmon-DNA claim.

Why are PRP and exosomes most often discussed as adjuncts rather than standalone protocols?

Because the published evidence supports the adjunct framing more cleanly than the standalone-therapy framing. The careful Cheongdam consult is likelier to articulate exosomes and PRP as adjuncts to a wider regimen — paired with microneedling, with radiofrequency, with the cellular protocols themselves — than as standalone interventions. The hedged register the literature supports is the conservative reading.

What questions should a careful patient ask at the PRP or exosome consult?

The kit-based or open-system framing, the concentration factor, the leukocyte register, the activator decision; for exosomes, the supplier, the lot identification, the NTA characterisation framework, the regulatory standing of the specific product, and the delivery format — topical-after-device or injectable. A practice that articulates these cleanly is working under tighter clinical discipline than one that does not.